摘要
目的探讨经皮经肝胆管穿刺引流、内镜逆行胰胆管造影及手术中行胆管支架置入治疗恶性梗阻性黄疸的效果。方法回顾性分析116例行金属胆管支架置入术治疗恶性梗阻性黄疸患者的临床资料。结果经皮经肝胆管穿刺引流置入支架成功率为88.1%,并发症发生率为4.8%,中位生存时间为27周;经内镜逆行胰胆管造影置入支架成功率为86.0%,并发症发生率为5.3%,中位生存时间为25周;手术中胆管支架放置成功率为100%,并发症发生率为13.3%,中位生存时间为23周。结论经皮经肝胆管穿刺引流及经内镜逆行胰胆管造影胆管支架置入术可作为恶性梗阻性黄疸患者姑息性治疗的首选方法。
Objective To investigate the therapeutic effect of biliary stent insertion via percutaneous transhepatic cholangial drainage,percutaneous transhepatic cholangial drainage and operation for malignant obstructive jaundice.Methods The clinical data of 116 patients receiving biliary stent for malignant obstructive jaundice were analyzed retrospectively.Results The successful rate of stent insertion,the complication rate and the median survival time were 88.1%,4.8% and 27 weeks respectively in the patients receiving stent via percutaneous transhepatic cholangial drainage,86.0%,5.3% and 25 weeks respectively in the patients receiving stent via endoscopic retrograde cholangiopancreatography,and were 100.0%,13.3% and 23 weeks respectively in the patients receiving operation.Conclusion It is the first choice to insert stent via percutaneous transhepatic cholangial drainage plus endoscopic retrograde cholangiopancreatography in the palliative therapy of malignant obstructive jaundice.
出处
《中华实用诊断与治疗杂志》
2011年第9期867-869,共3页
Journal of Chinese Practical Diagnosis and Therapy
关键词
肿瘤
黄疸
支架
Tumor
jaundice
stent